Please provide your email address to receive an email when new articles are posted on . Alcohol use is a significant risk factor for steatotic liver disease progression. Patients with metabolic or ...

Cirrhosis is the result of long-term liver injury where healthy tissue is replaced with scar tissue (fibrosis). Common causes of cirrhosis include alcohol use disorder (AUD), nonalcoholic fatty liver ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Right now, patients with obesity and cirrhosis ...

For patients with metabolic dysfunction–associated steatotic liver disease (MASLD) and diabetes, treatment with a glucagon-like peptide 1 receptor agonist (GLP-1 RA) may protect against progression to ...

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...

Fatty liver disease, encompassing metabolic-associated fatty liver disease (MAFLD) and alcohol-associated liver disease (ALD), is now a significant global health issue. MAFLD is closely linked to ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of the global population and is a key driver of cirrhosis and liver-related mortality. While chronological age is a ...

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. In a new decades-long study, ...

Cirrhosis of the liver is a chronic and progressive disease in which healthy liver cells are slowly replaced by scar tissue, severely impairing vital liver functions such as detoxification, hormone ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that ...

Medically reviewed by Josephine Hessert, DO Key Takeaways Alcohol is a known liver toxin, and heavy alcohol use increases the risk of liver disease and other health problems.Drinking soda, including ...

New research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early liver fibrosis & cirrhosis and may signal broader chronic disease burden.